FFCP PHASE1:Mm9::chr2:164829847..164829859,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=228869|HGNC=|MCL_coexpression_id=11|UniProt=|association_with_transcript=303bp_to_ENSMUST00000123347_5end|description=CAGE_peak_5_at_Ncoa5_5end|id=chr2:164829847..164829859,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0002610,1.88e-08,3|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002113!1.57e-27!14;UBERON:0003918!1.57e-27!14;UBERON:0005095!1.57e-27!14;UBERON:0007687!1.57e-27!14;UBERON:0006554!4.58e-24!16;UBERON:0001008!1.23e-22!17;UBERON:0000489!2.79e-18!21;UBERON:0003103!9.46e-09!43;UBERON:0005172!1.26e-07!49;UBERON:0005173!1.26e-07!49;UBERON:0002417!1.26e-07!49;UBERON:0000916!1.26e-07!49|ontology_enrichment_uberon_v019_2=UBERON:0002113,6.28e-15,14;UBERON:0003918,6.28e-15,14;UBERON:0011143,6.28e-15,14;UBERON:0005095,6.28e-15,14;UBERON:0007687,6.28e-15,14;UBERON:0006554,8.03e-12,18;UBERON:0001008,3.01e-11,19;UBERON:0000489,2.91e-10,21;UBERON:0004684,1.88e-08,3;UBERON:0002275,1.88e-08,3|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.510259740906419,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.10115880999389,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.702222100658759,0,0,0,0,0,0,0,0,0,0,0.34255163915718,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.203651327845314,0.193952487167626,0.280543279561274,0.126473074248515,3.54264355151045,5.33795674660674,3.70191491765402,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p5@Ncoa5}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=228869 | |||
|HGNC= | |||
|MCL_coexpression_id=11 | |||
|TSSclassifier=NA | |||
|UniProt= | |||
|association_with_transcript=303bp_to_ENSMUST00000123347_5end | |||
|cluster_id=chr2:164829847..164829859,- | |||
|description=CAGE_peak_5_at_Ncoa5_5end | |||
|id=chr2:164829847..164829859,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0002610,1.88e-08,3 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002113!1.57e-27!14;UBERON:0003918!1.57e-27!14;UBERON:0005095!1.57e-27!14;UBERON:0007687!1.57e-27!14;UBERON:0006554!4.58e-24!16;UBERON:0001008!1.23e-22!17;UBERON:0000489!2.79e-18!21;UBERON:0003103!9.46e-09!43;UBERON:0005172!1.26e-07!49;UBERON:0005173!1.26e-07!49;UBERON:0002417!1.26e-07!49;UBERON:0000916!1.26e-07!49 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002113,6.28e-15,14;UBERON:0003918,6.28e-15,14;UBERON:0011143,6.28e-15,14;UBERON:0005095,6.28e-15,14;UBERON:0007687,6.28e-15,14;UBERON:0006554,8.03e-12,18;UBERON:0001008,3.01e-11,19;UBERON:0000489,2.91e-10,21;UBERON:0004684,1.88e-08,3;UBERON:0002275,1.88e-08,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.510259740906419,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.10115880999389,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.702222100658759,0,0,0,0,0,0,0,0,0,0,0.34255163915718,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.203651327845314,0.193952487167626,0.280543279561274,0.126473074248515,3.54264355151045,5.33795674660674,3.70191491765402,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p5@Ncoa5 | |||
}} |
Latest revision as of 03:59, 26 September 2015
Short description: | p5@Ncoa5 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_5_at_Ncoa5_5end |
Coexpression cluster: | MCL_coexpression_mm9:11 |
Association with transcript: | 303bp_to_ENSMUST00000123347_5end |
EntrezGene: | Ncoa5 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
raphe nuclei neuron | 1.88e-08 | 3 |
Ontology term | p-value | n |
---|---|---|
kidney | 6.28e-15 | 14 |
kidney mesenchyme | 6.28e-15 | 14 |
upper urinary tract | 6.28e-15 | 14 |
kidney rudiment | 6.28e-15 | 14 |
kidney field | 6.28e-15 | 14 |
urinary system structure | 8.03e-12 | 18 |
renal system | 3.01e-11 | 19 |
cavitated compound organ | 2.91e-10 | 21 |
raphe nuclei | 1.88e-08 | 3 |
reticular formation | 1.88e-08 | 3 |